CME Group Inc (NASDAQ:CME) currently has a daily average trading volume of 2.65M but it saw 2221647 shares traded in last market. With a market cap of 101.53B USD, the company’s current market price of $281.74 came rising about 1.39 while comparing to the previous closing price of $277.87. In past 52 weeks, the stock remained buoying in the range of price level as high as $286.48 and as low as $186.08.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which upgraded the stock as “Overweight” in its note to investors issued on April 08, 2025, recommending a price target of $301 for it. Raymond James upgraded its recommendation for the stock as a “Outperform” from “Mkt Perform” on March 10, 2025 while assigning a price target of $287. Citigroup issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $255 and $250.
Over the week, CME’s stock price is moving 5.81% up while it is 6.09% when we observe its performance for the past one month. Year-to-date it is 21.32% up and over the past year, the stock is showing an upside performance of 35.47%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 2.97 while estimate for next year EPS is 11.18. In next quarter, company is expected to be making quarterly sales of $1.61B as analysts are expecting the sales for current fiscal year at $6.54B and seeing the company making $6.85B in sales next year. Moreover, analysts are in estimates of $1.68B for current-quarter revenue.
Currently, CME Group Inc’s total number of outstanding shares is 359.65M with 0.44% of that held by the insiders while 91.70% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 11.64% and return on equity (ROE) at 13.40%. It has a price to earnings ratio (P/E ratio) of 28.32 while having a 24.28 of forward P/E ratio. Stock’s beta reads 0.45. Stock has a price to book (P/B) ratio of 3.75 while price to sale or P/S ratio amounts to 16.16. Its return on asset (ROA) is 2.50% on average.
